July 2014

Benefits, Risks of SGLT2 Inhibitors Explored at Session

July 22, 2014

Article

Evidence-Based Diabetes Management

ADA 74th Scientific Sessions

Sessions Highlight Strides in

July 22, 2014

Article

Evidence-Based Diabetes Management

ADA 74th Scientific Sessions

Results Presented on Motivating Patients With Diabetes

July 22, 2014

Article

Evidence-Based Diabetes Management

ADA 74th Scientific Sessions

Diabetes Navigator Program Reduces A1C Levels for Patients in Alabama

July 22, 2014

Article

Evidence-Based Diabetes Management

ADA 74th Scientific Sessions

Afrezza, Inhaled Insulin, Wins FDA Approval

July 22, 2014

Article

Evidence-Based Diabetes Management

Can Early Use of Insulin, GLP-1 Halt Diabetes Progression?

July 22, 2014

Article

Evidence-Based Diabetes Management

ADA 74th Scientific Sessions

Integrated Treatment for Diabetes, Depression Gains Notice, With Help from ACA

July 21, 2014

Article

Evidence-Based Diabetes Management

Value-Engineered Translation: Developing Biotherapeutics That Align With Health-System Needs

July 21, 2014

Article

Evidence-Based Diabetes Management

Commentary

A Novel Pharmaceutical-ACO Collaboration: the Merck/Heritage Provider Network Open Innovation Challenge

July 21, 2014

Article

Evidence-Based Diabetes Management

Accountable care is forcing providers to develop new capacities and strategies for managing cost and quality trends. Prospectively managing the health of populations requires shifting the focus of care delivery from episodic interventions to continuous population management. As a result, accountable care organizations (ACOs) are dedicating considerable focus to developing the infrastructure and tools needed to help patients manage their chronic conditions. This is a significant departure from traditional care-delivery models and will require provider organizations to develop new partnerships and embrace new methods.